Literature DB >> 3311436

Antibodies to Pf155, a major antigen of Plasmodium falciparum: seroepidemiological studies in Haiti.

P Deloron, Y T Duverseau, A Zevallos-Ipenza, R Magloire, P S Stanfill, P Nguyen-Dinh.   

Abstract

The presence of malaria parasites and the serological antibody responses against whole Plasmodium falciparum and the Pf155 antigen were studied in the population of a small rural locality in Haiti in December 1985. Only 7 (1.5%) of the individuals were found to be infected with P. falciparum, the only species observed. Antibodies to P. falciparum were detected in an ELISA in 38.2% of the sera, the positivity rates being age-related. Anti-Pf155 antibodies were detected in 12.5% and 13.6% of individuals by two different techniques used. The anti-Pf155 positivity rates increased only after 25 years of age. No trends were detected for a clear-cut protective value of Pf155 antibodies against clinical malaria and further longitudinally conducted field surveys are needed to satisfactorily assess the potential protective effect of Pf155 antibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311436      PMCID: PMC2491017     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis.

Authors:  V C Tsang; J M Peralta; A R Simons
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

2.  The enzyme-linked immunosorbent assay (ELISA) for malaria. I. The use of in vitro-cultured Plasmodium falciparum as antigen.

Authors:  H C Spencer; W E Collins; W Chin; J C Skinner
Journal:  Am J Trop Med Hyg       Date:  1979-11       Impact factor: 2.345

3.  Anti-Plasmodium falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity.

Authors:  M Wahlgren; A Björkman; H Perlmann; K Berzins; P Perlmann
Journal:  Am J Trop Med Hyg       Date:  1986-01       Impact factor: 2.345

4.  Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion.

Authors:  B Wåhlin; M Wahlgren; H Perlmann; K Berzins; A Björkman; M E Patarroyo; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.

Authors:  H Perlmann; K Berzins; M Wahlgren; J Carlsson; A Björkman; M E Patarroyo; P Perlmann
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

  5 in total
  4 in total

1.  Possible relationship between Plasmodium falciparum ring-infected erythrocyte surface antigen (RESA) and host cell resistance to destruction by chemicals.

Authors:  Augustine U Orjih; Preethi T Cherian
Journal:  Parasitol Res       Date:  2013-09-05       Impact factor: 2.289

2.  Antibodies to the ring-infected erythrocyte surface antigen of Plasmodium falciparum elicited by infection with Plasmodium malariae.

Authors:  A J Sulzer; P Deloron; R A Cantella; W E Collins; P Nguyen-Dinh
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

3.  Circulating stable antigens at higher levels down-regulate antibody responses to Plasmodium falciparum.

Authors:  B Chumpitazi; J P Lepers; M Rason; A Meunier; C Boudin; P Ambroise-Thomas
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

Review 4.  Malaria treatment policies and drug efficacy in Haiti from 1955-2012.

Authors:  Michael E von Fricken; Thomas A Weppelmann; Jennifer D Hosford; Alexander Existe; Bernard A Okech
Journal:  J Pharm Policy Pract       Date:  2013-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.